Broadening INPP5E phenotypic spectrum: detection of rare variants in syndromic and non-syndromic IRD
Riccardo Sangermano(Radboud University Nijmegen), Kinga M. Bujakowska(Massachusetts Eye and Ear Infirmary), Anne B. Fulton(Boston Children's Hospital), Anna Larson(Massachusetts Eye and Ear Infirmary), Naomi E. Wagner(Massachusetts Eye and Ear Infirmary), Erin Zampaglione(Massachusetts Eye and Ear Infirmary), Ana Berta Sousa(Administração Regional de Saúde de Lisboa e Vale do Tejo), Tamar Ben‐Yosef(Technion – Israel Institute of Technology), Mariana Neves(Centro Hospitalar Lisboa Norte), Dror Sharon(Hebrew University of Jerusalem), Rachel M. Huckfeldt(Penn Presbyterian Medical Center), Vincent Dunet(University Hospital of Lausanne), Eyal Banin(Hebrew University of Jerusalem), Eric A. Pierce(Broad Institute), Virginie G. Peter(University Hospital of Bern), Alaa AlTalbishi(Hebrew University of Jerusalem), Rola Ba‐Abbad(Moorfields Eye Hospital), Mathieu Quinodoz(University of Leicester), Boris Rosin(Hebrew University of Jerusalem), Michel Michaelides(Moorfields Eye Hospital), Gavin Arno(Greenwood Genetic Center), Emily Place(MACOM (United States)), Iris Deitch(Massachusetts Eye and Ear Infirmary), Andrew R. Webster(Moorfields Eye Hospital), Carlo Rivolta(University of Lausanne)
Cited by 23
Related Papers
Safety and Efficacy of Gene Transfer for Leber's Congenital Amaurosis
|New England Journal of Medicine|2008|2.1k
Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins.
|Proceedings of the National Academy of Sciences|1995|1.3k
Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization.
|Proceedings of the National Academy of Sciences|1995|1k